DELCF.US Delic Holdings Inc
- Market cap
- USD 885.00
- P/E
- -
- P/B
- 0.00x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2023.
Is DELCF.US undervalued?
Graham numberThe Graham number of Delic Holdings Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Delic Holdings Inc fundamental analysis
No fundamental analysis for Delic Holdings Inc yet.
Delic Holdings Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Delic Holdings Inc
Delic Holdings Corp. provides various medicines and treatments in the United States and Canada. It operates The Delic, a creative platform that creates and hosts public discourse about psychedelic culture; Meet Delic, which organizes event to promote topics, such as safety and harm reduction, Hollywood, mental health and psychedelics, the power of integration, human performance, medicine, and other topics; Reality Sandwich, a public online education platform with approximate…
Full company profileDelic Holdings Inc financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
Delic Holdings Inc annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2023 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | - | 0.00 | 4.49M | 0.00 | 1.57M | - |
| Gross Profit | - | - | 1.21M | -74.8K | -32.4K | - |
| Operating Income | -9.13K | -41.1K | -137K | -384K | -5.88M | - |
| EBITDA | -9.13K | -41.1K | -137K | -384K | -5.75M | - |
| Net Income | -9.20K | -41.1K | -137K | -1.60M | -8.86M | - |
| EPS | 0.00 | 0.00 | 0.00 | -0.18 | -0.16 | - |
| Balance Sheet | ||||||
| Total Assets | - | 7.90K | 691K | 2.19M | 14.8M | 13.1M |
| Total Liabilities | - | 108K | 901K | 73.4K | 4.15M | 5.76M |
| Shareholders' Equity | - | -99.8K | -210K | 2.12M | 10.7M | 7.34M |
| Cash & Short-term Investments | - | 10.8K | 214K | 1.63M | 2.40M | 392K |
| Total Debt | - | - | - | - | 1.86M | 3.65M |
| Cash Flow | ||||||
| Operating Cash Flow | - | -23.6K | -147K | -861K | -4.36M | - |
| Capital Expenditure | - | 0.00 | 16.42 | 21.0K | 21.0K | 705K |
| Free Cash Flow | - | -23.6K | -147K | -861K | -4.38M | - |
| Ratios | ||||||
| ROE | - | - | - | -75.5% | -83.0% | - |
| ROA | - | -520.7% | -19.9% | -73.0% | -59.7% | - |
| Net Profit Margin | - | - | -3.1% | - | -565.9% | - |
| Debt to Equity | - | - | - | - | 0.17x | 0.50x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Delic Holdings Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2021 | - | - | - |
| 2020 | CAD 80.0K | 0.01 | - |
| 2019 | CAD 80.0K | 0.00 | - |
| 2018 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Delic Holdings Inc
- Insiders 13.85%
- Institutions 0.00%
- Public & others 86.15%
- Shares outstanding 88.0M
- Free float 86.8M
Delic Holdings Inc company profile
- Company name
- Delic Holdings Inc
- Ticker
- DELCF.US
- ISIN
- CA24689D1096
- Exchange
- USA Stocks
- Sector
- Communication Services
- Industry
- Interactive Media & Services
- Employees
- 116
- Fiscal year end
- December
- Address
- 885 West Georgia Street, Vancouver, BC, Canada, V6C 3E8
- Phone
- 708 515 4925
- Website
- deliccorp.com
About Delic Holdings Inc
Delic Holdings Corp. provides various medicines and treatments in the United States and Canada. It operates The Delic, a creative platform that creates and hosts public discourse about psychedelic culture; Meet Delic, which organizes event to promote topics, such as safety and harm reduction, Hollywood, mental health and psychedelics, the power of integration, human performance, medicine, and other topics; Reality Sandwich, a public online education platform with approximately 10,000 pieces of content, including psychedelic guides, news, and culture; and Delic Radio, a podcast that discusses topics related to the psychedelic space with experts comprising discussions relating to news, science, culture, medicine, current affairs, and policy. The company also focuses on developing intellectual property through research and development for cannabis and psychedelics. In addition, it owns and operates two ketamine infusion treatment clinics; and thirteen ketamine infusion treatment clinics. The company is headquartered in Vancouver, Canada.
Delic Holdings Inc management
3- Ms. Jackee StangCo-Founder & Chief Creative Officer
- Mr. Kevin NicholsonCEO & COO
- Dr. Markus Roggen Ph.D.C.S.O